Clinical Trial Update: A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of Botox versus solifenacin for overactive bladder with urinary incontinence has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• Solifenacin (solifenacin)

Snippet

Sponsor: Allergan | Conditions: Overactive Bladder, Urinary Incontinence | Phase 3 | Status: COMPLETED | Results posted: 2016-01-12